Cargando…

Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes

The airborne nature of coronavirus transmission makes it critical to develop new barrier technologies that can simultaneously reduce aerosol and viral spread. Here, we report nanostructured membranes with tunable thickness and porosity for filtering coronavirus-sized aerosols, combined with antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Rollie, Vogler, Ronald J., Bernard, Matthew, Concolino, Jacob, Hersh, Louis B., Wei, Yinan, Hastings, Jeffrey Todd, Dziubla, Thomas, Baldridge, Kevin C., Bhattacharyya, Dibakar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674191/
https://www.ncbi.nlm.nih.gov/pubmed/36406238
http://dx.doi.org/10.1038/s43246-022-00256-0
_version_ 1784833101989412864
author Mills, Rollie
Vogler, Ronald J.
Bernard, Matthew
Concolino, Jacob
Hersh, Louis B.
Wei, Yinan
Hastings, Jeffrey Todd
Dziubla, Thomas
Baldridge, Kevin C.
Bhattacharyya, Dibakar
author_facet Mills, Rollie
Vogler, Ronald J.
Bernard, Matthew
Concolino, Jacob
Hersh, Louis B.
Wei, Yinan
Hastings, Jeffrey Todd
Dziubla, Thomas
Baldridge, Kevin C.
Bhattacharyya, Dibakar
author_sort Mills, Rollie
collection PubMed
description The airborne nature of coronavirus transmission makes it critical to develop new barrier technologies that can simultaneously reduce aerosol and viral spread. Here, we report nanostructured membranes with tunable thickness and porosity for filtering coronavirus-sized aerosols, combined with antiviral enzyme functionalization that can denature spike glycoproteins of the SARS-CoV-2 virus in low-hydration environments. Thin, asymmetric membranes with subtilisin enzyme and methacrylic functionalization show more than 98.90% filtration efficiency for 100-nm unfunctionalized and protein-functionalized polystyrene latex aerosol particles. Unfunctionalized membranes provided a protection factor of 540 ± 380 for coronavirus-sized particle, above the Occupational Safety and Health Administration’s standard of 10 for N95 masks. SARS-CoV-2 spike glycoprotein on the surface of coronavirus-sized particles was denatured in 30 s by subtilisin enzyme-functionalized membranes with 0.02-0.2% water content on the membrane surface.
format Online
Article
Text
id pubmed-9674191
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-96741912022-11-18 Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes Mills, Rollie Vogler, Ronald J. Bernard, Matthew Concolino, Jacob Hersh, Louis B. Wei, Yinan Hastings, Jeffrey Todd Dziubla, Thomas Baldridge, Kevin C. Bhattacharyya, Dibakar Commun Mater Article The airborne nature of coronavirus transmission makes it critical to develop new barrier technologies that can simultaneously reduce aerosol and viral spread. Here, we report nanostructured membranes with tunable thickness and porosity for filtering coronavirus-sized aerosols, combined with antiviral enzyme functionalization that can denature spike glycoproteins of the SARS-CoV-2 virus in low-hydration environments. Thin, asymmetric membranes with subtilisin enzyme and methacrylic functionalization show more than 98.90% filtration efficiency for 100-nm unfunctionalized and protein-functionalized polystyrene latex aerosol particles. Unfunctionalized membranes provided a protection factor of 540 ± 380 for coronavirus-sized particle, above the Occupational Safety and Health Administration’s standard of 10 for N95 masks. SARS-CoV-2 spike glycoprotein on the surface of coronavirus-sized particles was denatured in 30 s by subtilisin enzyme-functionalized membranes with 0.02-0.2% water content on the membrane surface. 2022 2022-05-24 /pmc/articles/PMC9674191/ /pubmed/36406238 http://dx.doi.org/10.1038/s43246-022-00256-0 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . Reprints and permission information is available at http://www.nature.com/reprints
spellingShingle Article
Mills, Rollie
Vogler, Ronald J.
Bernard, Matthew
Concolino, Jacob
Hersh, Louis B.
Wei, Yinan
Hastings, Jeffrey Todd
Dziubla, Thomas
Baldridge, Kevin C.
Bhattacharyya, Dibakar
Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title_full Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title_fullStr Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title_full_unstemmed Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title_short Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
title_sort aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674191/
https://www.ncbi.nlm.nih.gov/pubmed/36406238
http://dx.doi.org/10.1038/s43246-022-00256-0
work_keys_str_mv AT millsrollie aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT voglerronaldj aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT bernardmatthew aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT concolinojacob aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT hershlouisb aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT weiyinan aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT hastingsjeffreytodd aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT dziublathomas aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT baldridgekevinc aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes
AT bhattacharyyadibakar aerosolcaptureandcoronavirusspikeproteindeactivationbyenzymefunctionalizedantiviralmembranes